Ewing Sarcoma: Clinical State-of-the-Art

Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family tumors (ESFT)

(2017) R. B. Womer et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized comparison of VAC versus VAI chemotherapy (CT) as consolidation for standard risk (SR) Ewing sarcoma tumor (ES): Results of the Euro-EWING.99-R1 trial.

(2017) O. Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical features and outcomes in patients with extraskeletal ewing sarcoma

(2011) Mark A. Applebaum et al.   CANCER

Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma

(2011) Arthur K. Liu et al.   PEDIATRIC BLOOD & CANCER

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

(2010) S. Ferrari et al.   ANNALS OF ONCOLOGY

Ethnic and racial differences in patients with Ewing sarcoma

(2010) Jennifer Worch et al.   CANCER

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters

(2010) Timm Denecke et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Impact ofEWS-ETSFusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial

(2010) Marie-Cecile Le Deley et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term Survivors of Childhood Ewing Sarcoma: Report From the Childhood Cancer Survivor Study

(2010) J. P. Ginsberg et al.   JNCI-Journal of the National Cancer Institute

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

(2009) Elai Davicioni et al.   AMERICAN JOURNAL OF PATHOLOGY

Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases

(2009) S Burdach et al.   BONE MARROW TRANSPLANTATION

The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)

(2009) Julia Haeusler et al.   CANCER

Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome

(2009) Katia Scotlandi et al.   JOURNAL OF CLINICAL ONCOLOGY

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2008) M. Paulussen et al.   ANNALS OF ONCOLOGY

Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients

(2008) Michael Paulussen et al.   JOURNAL OF CLINICAL ONCOLOGY

Ewing’s Tumors over the Age of 40 – a Retrospective Analysis of 47 Patients Treated According to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99

(2008) Sebastian Pieper et al.   Oncology Research and Treatment